Skip to main content
      RheumNow’s expanded coverage of the #ACR24 annual meeting is sponsored in part by Novartis. All content is chosen by R

      Dr. John Cush RheumNow

      9 months 3 weeks ago
      RheumNow’s expanded coverage of the #ACR24 annual meeting is sponsored in part by Novartis. All content is chosen by RheumNow & its faculty.
      Are emulation ‘trials’ helpful, despite the biases that occur with observational data, or do they truly mimic the results of randomized controlled trials (RCTs)?
      In the @ACRheum MSK Ultrasound Guidance:

      In difficult-to-treat RA, MSUS can distinguish symptoms of active synovitis fr

      David Liew drdavidliew

      9 months 3 weeks ago
      In the @ACRheum MSK Ultrasound Guidance: In difficult-to-treat RA, MSUS can distinguish symptoms of active synovitis from other sources of pain. (consensus: mod) CURRENTLY do you often use ultrasound when RA gets difficult to treat, and synovitis isn't obvious? #ACR24 @RheumNow
      Phase 2 DBRCT of daxdilimab, an immunoglobulin-like transcript 7 to target plasmacytoid dendritic cells

      No difference i

      Mike Putman EBRheum

      9 months 3 weeks ago
      Phase 2 DBRCT of daxdilimab, an immunoglobulin-like transcript 7 to target plasmacytoid dendritic cells No difference in primary outcome... but kiiiinda looks like something there? I dislike Phase 2's; should go straight to Phase 3 if able #ACR24 @rheumnow Abstr#1542 https://t.co/osDWDskfnA
      The DESIR cohort of Dr. Franc et al. showed that female pts with early axSpA had significantly lower AMH levels vs. gene

      sheila RHEUMarampa

      9 months 3 weeks ago
      The DESIR cohort of Dr. Franc et al. showed that female pts with early axSpA had significantly lower AMH levels vs. general population reflecting low ovarian reserve & fertility. Mechanism? Bigger studies need to be done @RheumNow #ACR24 abs577 https://t.co/842rX79bq6
      @KDAO2011 help me out here; what is the point of analyses like this?

      NO difference in PROs comparing voclo vs plbo...

      Mike Putman EBRheum

      9 months 3 weeks ago
      @KDAO2011 help me out here; what is the point of analyses like this? NO difference in PROs comparing voclo vs plbo... ...but if you split by responder status its different Prescribing the drug doesn't help PROs, but when it works it works? 🤔 #ACR @RheumNow Abstr#1538 https://t.co/339drHwUuK
      This is very true. We showed a number of years ago that patients with gout have increased platelet activation at baselin

      Richard Conway RichardPAConway

      9 months 3 weeks ago
      This is very true. We showed a number of years ago that patients with gout have increased platelet activation at baseline, which then dramatically increases during flare. Treating gout properly may ameliorate this. #ACR24 @RheumNow https://t.co/VL8fy3ezjx https://t.co/9XdrG1NG9c
      Remote monitoring SHOULD increasingly be part of our care. BUT I don't think it neccessarily will. Just like with confer

      Richard Conway RichardPAConway

      9 months 3 weeks ago
      Remote monitoring SHOULD increasingly be part of our care. BUT I don't think it neccessarily will. Just like with conferences reverting to non-virtual when facilitating virtual is logical from a learning perspective. There are other limiting interests in play #ACR24 @RheumNow https://t.co/UN3jGa7jVZ
      One situation I've seen MSK ultrasound have impact ++ in the real-world is showing patients their own RA disease activit

      David Liew drdavidliew

      9 months 3 weeks ago
      One situation I've seen MSK ultrasound have impact ++ in the real-world is showing patients their own RA disease activity. Arthritis might be the invisible disease sometimes, but seeing it in full Doppler colour on screen means a lot to many. #ACR24 MSK USS Guidance @RheumNow https://t.co/wd9s6FAfp4
      A framework for critical conversations with patients
      (because the big decisions deserve high quality counselling, otherw

      David Liew drdavidliew

      9 months 3 weeks ago
      A framework for critical conversations with patients (because the big decisions deserve high quality counselling, otherwise the consequences are real) #ACR24 16S17 @RheumNow https://t.co/fiwYY1DuMq
      "Do not fear RPF." - John Stone

      Retroperitoneal fibrosis certainly feels challenging at times, and radiologic features

      David Liew drdavidliew

      9 months 3 weeks ago
      "Do not fear RPF." - John Stone Retroperitoneal fibrosis certainly feels challenging at times, and radiologic features might stay even after functional improvement but we've come a long way (although, despite B cell depletion, there's plenty more to do) #ACR24 16S26 @RheumNow https://t.co/2Y3buXrAFY
      The @ACRheum RA outcome measures toolkit has all the relevant tools for measuring outcomes in rheumatoid arthritis (and

      David Liew drdavidliew

      9 months 3 weeks ago
      The @ACRheum RA outcome measures toolkit has all the relevant tools for measuring outcomes in rheumatoid arthritis (and exactly how to do it). https://t.co/GZ7tZ6fNMK Great for all US rheumatologists, but also very handy for all of us globally #ACR24 16S30 @JYazdany @RheumNow https://t.co/MSHA353MKR
      Gender Differences in AxSpA
      Disease Activity in RA-ILD
      ×